The aim of the SYNTAX II trial was to compare PCI using first-generation drug-eluting stents with CABG surgery for patients with complex coronary artery disease.
On Monday 11th September 2017, a panel of experts in the field met in London to discuss the results of the trial.
Moderator:
Dr. Justin Davies (London, United Kingdom)
Panel:
Prof Javier Escaned (Madrid, Spain)
Prof Amir Lerman (Minnesota, USA)
Prof Bruce Samuels (Los Angeles, USA)
Dr Andrew Sharp (Exeter, UK)
• To increase awareness of the key outcomes from Syntax II
• To discuss the data in wider historical context
• To discuss clinical implications of this data
• To summarise and debate future research to be conducted as a result of Syntax II
